James Maitland is an expert in pharmaceutical litigation and regulatory affairs, with a specific focus on how Pharmacy Benefit Managers (PBMs) influence the U.S. prescription drug market. Today, he shares his insights into the recent decision by Andrew Ferguson to rejoin the FTC's lawsuit
Physics World has published an article discussing the development and application of a portable multiphoton microscopy system aimed at rapid cancer diagnosis. This advanced imaging technology leverages femtosecond laser pulses for nonlinear optical imaging, producing high-resolution,
The Department of Veterans Affairs (VA) has provided an important update on its efforts to modernize its electronic health record (EHR) system by announcing that nine additional medical centers will implement the Oracle EHR by 2026. This market analysis aims to examine current trends, challenges,
Companion diagnostics have revolutionized the field of precision oncology by enabling the identification of patients who will benefit most from targeted therapies. Focusing on the genetic and molecular characteristics of an individual's cancer, these diagnostics have significantly improved
The modern healthcare system grapples with persistent challenges in identifying and closing care gaps for patients, which often leads to disappointing care quality and missed opportunities for improving patient outcomes. Providers frequently struggle to access comprehensive patient information,
Johnson & Johnson’s commitment to investing $55 billion in U.S. manufacturing, research, and development over the next four years marks a significant expansion for the renowned pharmaceutical company. Announced by CEO Joaquin Duato on March 21, this ambitious initiative is intended to bolster t
A groundbreaking development in the realm of medical imaging is offering refreshing insights into the lingering effects of COVID-19, known as long COVID, which continues to affect countless individuals even after initial recovery. The new approach utilizes a specialized PET imaging method designed
23andMe’s weekend bankruptcy filing has ignited concerns among consumers who provided the company with their genetic information and reignited discussions on data privacy among policymakers and security experts. Among the genetic testing company’s assets is the genetic information of more than 15 mi
The Llantrisant Health Park near the Royal Glamorgan Hospital is poised for a transformational role as a regional diagnostic and treatment center for patients in South East Wales. It will serve areas including Gwent, Cardiff, the Vale of Glamorgan, and the Glamorgan Valleys. Health officials are
Juggling clinical operations and a maze of legal mandates (from protecting patient records to navigating complex reimbursement protocols) increases the pressure on professionals in the IT industry. One misstep could mean financial penalties, lawsuits, and lasting damage to your business’ cre
